0001595097-14-000005.txt : 20140312 0001595097-14-000005.hdr.sgml : 20140312 20140312165136 ACCESSION NUMBER: 0001595097-14-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140312 DATE AS OF CHANGE: 20140312 EFFECTIVENESS DATE: 20140312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corbus Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001595097 IRS NUMBER: 464348039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-213463 FILM NUMBER: 14688113 BUSINESS ADDRESS: STREET 1: 142 WEST 57TH STREET STREET 2: SUITE 4A CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-367-5905 MAIL ADDRESS: STREET 1: 142 WEST 57TH STREET STREET 2: SUITE 4A CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: SAV Acquisition Corp DATE OF NAME CHANGE: 20131220 D 1 primary_doc.xml X0707 D LIVE 0001595097 Corbus Pharmaceuticals Holdings, Inc. 142 WEST 57TH STREET SUITE 4A NEW YORK NY NEW YORK 10019 646-367-5905 DELAWARE SAV Acquisition Corp Corporation true 2013 David Hochman 142 W. 57th Street Suite 4A New York NY NEW YORK 10019 Executive Officer Director John Brancaccio 142 W. 57th Street Suite 4A New York NY NEW YORK 10019 Executive Officer Investing Decline to Disclose 06b false 2014-03-05 false true false 0 N/A None None None N/A N/A N/A XX Unknown 00000 NY NEW YORK false 30000 19750 10250 false 3 0 0 0 false Corbus Pharmaceuticals Holdings, Inc. /s/ David Hochman David Hochman President 2014-03-12